Catalent Chief Scientific Officer to Present at Upcoming Symposium of the International Consortium for Advanced Medicines Manufacturing
Retrieved on:
Thursday, April 20, 2023
SOMERSET, N.J., April 20, 2023 /PRNewswire-PRWeb/ -- Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that its Vice President & Chief Scientific Officer, Julien Meissonnier, will present at the upcoming 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), to be held at the Royal Sonesta Hotel, Cambridge, Massachusetts, on April 27 - 28, 2023.
Key Points:
- Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that its Vice President & Chief Scientific Officer, Julien Meissonnier, will present at the upcoming 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), to be held at the Royal Sonesta Hotel, Cambridge, Massachusetts, on April 27 - 28, 2023.
- SOMERSET, N.J., April 20, 2023 /PRNewswire-PRWeb/ -- Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that its Vice President & Chief Scientific Officer, Julien Meissonnier, will present at the upcoming 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), to be held at the Royal Sonesta Hotel, Cambridge, Massachusetts, on April 27 - 28, 2023.
- In his role at Catalent, Mr. Meissonnier leads new product development, providing customers with scientific advice when initiating a relationship and later, in developing their programs.
- He oversees Catalent's scientific community, which has more than 3,000 scientists, engineers, and technicians, united in their aim to accelerate life science innovation.